Neurobiological Tech says group starts test . Neurobiological Technologies Inc said on Wednesday a research group has started a Phase II clinical trial of the company ' s neuroprotectant drug called Memantine . The group , called the Adult Aids Clinical Trials Group ( AACTG ) , is a clinical research network supported by the National Institute of Allergy and Infectious Diseases ( NIAID ) of the National Institutes of Health . The trial will evaluate Memantine ' s ability to reduce dementia and neuropathic pain in AIDS patients for which there are currently no effective treatments , the company said . Neurobiological Technologies will supply Memantine and will have the right to use the data from the trial for the further commercial development of Memantine , it said . 
